MX2019014772A - Formulaciones en gel de bisfosfocinas y usos de estas. - Google Patents
Formulaciones en gel de bisfosfocinas y usos de estas.Info
- Publication number
- MX2019014772A MX2019014772A MX2019014772A MX2019014772A MX2019014772A MX 2019014772 A MX2019014772 A MX 2019014772A MX 2019014772 A MX2019014772 A MX 2019014772A MX 2019014772 A MX2019014772 A MX 2019014772A MX 2019014772 A MX2019014772 A MX 2019014772A
- Authority
- MX
- Mexico
- Prior art keywords
- bisphosphocin
- gel formulations
- gel
- formulations
- disclosed
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Ophthalmology & Optometry (AREA)
- Cosmetics (AREA)
Abstract
Se describen formulaciones en gel que tienen actividad antimicrobiana. Se describen, además, métodos para usar la formulación en gel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762518262P | 2017-06-12 | 2017-06-12 | |
PCT/US2018/037151 WO2018231863A1 (en) | 2017-06-12 | 2018-06-12 | Bisphosphocin gel formulations and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019014772A true MX2019014772A (es) | 2020-02-07 |
Family
ID=64562861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019014772A MX2019014772A (es) | 2017-06-12 | 2018-06-12 | Formulaciones en gel de bisfosfocinas y usos de estas. |
Country Status (12)
Country | Link |
---|---|
US (4) | US11096954B2 (es) |
EP (2) | EP3638251B1 (es) |
JP (2) | JP7148994B2 (es) |
KR (2) | KR20200014904A (es) |
CN (1) | CN110753549A (es) |
AU (3) | AU2018282905B2 (es) |
BR (2) | BR122021011439B1 (es) |
CA (1) | CA3066722A1 (es) |
DK (1) | DK3638251T3 (es) |
FI (1) | FI3638251T3 (es) |
MX (1) | MX2019014772A (es) |
WO (1) | WO2018231863A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2604943C (en) | 2005-04-15 | 2013-09-17 | Clarus Therapeutics, Inc. | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
US8492369B2 (en) | 2010-04-12 | 2013-07-23 | Clarus Therapeutics Inc | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
WO2018165675A1 (en) * | 2017-03-10 | 2018-09-13 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
US11377468B2 (en) | 2017-03-10 | 2022-07-05 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
US11795192B2 (en) | 2017-03-10 | 2023-10-24 | Lakewood Amedex, Inc. | Antimicrobial compounds, compositions, and uses thereof |
US11123357B2 (en) * | 2018-10-17 | 2021-09-21 | Lakewood Amedex, Inc. | Methods and compositions for treating oral mucositis |
KR20240037174A (ko) * | 2021-07-22 | 2024-03-21 | 레이크우드 아메덱스, 인크. | 비스포스포신을 제조하기 위한 방법 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105782A (en) | 1975-03-07 | 1978-08-08 | Yu Ruey J | Treatment of acne and dandruff |
SE8004580L (sv) * | 1980-06-19 | 1981-12-20 | Draco Ab | Farmaceutisk beredning |
KR830005852A (ko) * | 1980-07-18 | 1983-09-14 | 미첼 페터 잭슨 | 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법 |
US4421769A (en) * | 1981-09-29 | 1983-12-20 | The Procter & Gamble Company | Skin conditioning composition |
DE3542516A1 (de) | 1985-12-02 | 1987-06-04 | Henkel Kgaa | Desinfektionsmittel |
DE3731255A1 (de) * | 1987-09-17 | 1989-04-06 | Boehringer Ingelheim Int | Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen |
US5153230A (en) | 1989-10-06 | 1992-10-06 | Perfective Cosmetics, Inc. | Topical skin cream composition |
US5167950A (en) | 1991-03-28 | 1992-12-01 | S. C. Johnson & Son | High alcohol content aerosol antimicrobial mousse |
US5208015A (en) * | 1991-07-23 | 1993-05-04 | Bristol-Myers Squibb Company | Topical anti-fungal agents having anti-inflammatory activity |
DE4333385C2 (de) | 1993-09-30 | 1997-01-30 | Friedrich A Spruegel | Flächendesinfektions- und Reinigungsmittel |
AU702897B2 (en) * | 1994-03-11 | 1999-03-11 | Procter & Gamble Company, The | Low pH, hydrolytically stable, cosmetic compositions containing acidic actives |
FR2718022B1 (fr) | 1994-04-01 | 1996-04-26 | Roussel Uclaf | Compositions cosmétiques ou dermatologiques et leur préparation. |
FR2722102B1 (fr) * | 1994-07-11 | 1996-08-23 | Cird Galderma | Utilisation de particules creuses deformables dans une composition cosmetique et/ou dermatologique, contenant des matieres grasses |
US5843998A (en) | 1997-06-30 | 1998-12-01 | Song; Jin | Skin blemish treatment |
US6627215B1 (en) | 1998-12-30 | 2003-09-30 | Oligos Etc. Inc. | Devices for improved wound management |
US7868162B2 (en) * | 1998-12-30 | 2011-01-11 | Lakewood-Amedex, Inc. | Antimicrobial and antiviral compounds and methods for their use |
US20020032164A1 (en) | 1998-12-30 | 2002-03-14 | Dale Roderic M. K. | Antimicrobial compounds and methods for their use |
US6211349B1 (en) | 1998-12-30 | 2001-04-03 | Oligos Etc., Inc. | Protonated/acidified nucleic acids and methods of use |
US6211162B1 (en) | 1998-12-30 | 2001-04-03 | Oligos Etc. Inc. | Pulmonary delivery of protonated/acidified nucleic acids |
US6156294A (en) * | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
WO2003032909A2 (en) * | 2001-10-18 | 2003-04-24 | Ilex Products, Inc. | Methods of treating skin with diphosphonate derivatives |
BRPI0410503B8 (pt) * | 2003-04-24 | 2021-05-25 | Galderma Sa | composição tópica e uso da composição |
CN1687100A (zh) * | 2005-04-05 | 2005-10-26 | 奥林格斯技术有限公司 | 修饰性核苷酸及其用途 |
EP2149375A1 (en) * | 2008-07-28 | 2010-02-03 | Despharma Kft. | Compositions for the treatment of dermatological diseases, and uses thereof |
WO2015075406A1 (en) * | 2013-11-19 | 2015-05-28 | Lipopeptide Ab | New treatment of chronic ulcers |
FR3041540B1 (fr) * | 2015-09-29 | 2018-10-26 | Galderma Research & Development | Composition nettoyante auto-moussante a rincer, contenant de l'ivermectine. |
-
2018
- 2018-06-12 WO PCT/US2018/037151 patent/WO2018231863A1/en active Application Filing
- 2018-06-12 DK DK18816615.1T patent/DK3638251T3/da active
- 2018-06-12 EP EP18816615.1A patent/EP3638251B1/en active Active
- 2018-06-12 EP EP23156658.9A patent/EP4241769A3/en active Pending
- 2018-06-12 AU AU2018282905A patent/AU2018282905B2/en active Active
- 2018-06-12 KR KR1020207000424A patent/KR20200014904A/ko active IP Right Grant
- 2018-06-12 BR BR122021011439-0A patent/BR122021011439B1/pt active IP Right Grant
- 2018-06-12 BR BR112019026073-0A patent/BR112019026073B1/pt active IP Right Grant
- 2018-06-12 JP JP2019567981A patent/JP7148994B2/ja active Active
- 2018-06-12 CA CA3066722A patent/CA3066722A1/en active Pending
- 2018-06-12 KR KR1020237004991A patent/KR20230031370A/ko not_active Application Discontinuation
- 2018-06-12 FI FIEP18816615.1T patent/FI3638251T3/fi active
- 2018-06-12 MX MX2019014772A patent/MX2019014772A/es unknown
- 2018-06-12 US US16/006,660 patent/US11096954B2/en active Active
- 2018-06-12 CN CN201880038759.5A patent/CN110753549A/zh active Pending
-
2020
- 2020-07-30 US US16/943,939 patent/US20200360415A1/en not_active Abandoned
-
2021
- 2021-08-09 US US17/396,989 patent/US20210361689A1/en active Pending
-
2022
- 2022-09-02 AU AU2022224829A patent/AU2022224829A1/en active Pending
- 2022-09-15 JP JP2022147051A patent/JP7470449B2/ja active Active
- 2022-12-16 US US18/083,378 patent/US20230125677A1/en active Pending
-
2024
- 2024-04-05 AU AU2024202211A patent/AU2024202211A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11096954B2 (en) | 2021-08-24 |
US20200360415A1 (en) | 2020-11-19 |
JP7470449B2 (ja) | 2024-04-18 |
BR112019026073B1 (pt) | 2021-11-03 |
EP3638251A1 (en) | 2020-04-22 |
EP3638251B1 (en) | 2024-03-06 |
JP7148994B2 (ja) | 2022-10-06 |
EP4241769A3 (en) | 2023-11-08 |
KR20200014904A (ko) | 2020-02-11 |
CA3066722A1 (en) | 2018-12-20 |
BR122021011439B1 (pt) | 2022-03-29 |
WO2018231863A1 (en) | 2018-12-20 |
AU2024202211A1 (en) | 2024-05-02 |
US20230125677A1 (en) | 2023-04-27 |
CN110753549A (zh) | 2020-02-04 |
FI3638251T3 (fi) | 2024-04-29 |
US20210361689A1 (en) | 2021-11-25 |
AU2018282905A1 (en) | 2019-12-19 |
DK3638251T3 (da) | 2024-05-13 |
US20180353529A1 (en) | 2018-12-13 |
EP3638251A4 (en) | 2021-03-10 |
JP2022183154A (ja) | 2022-12-08 |
BR112019026073A2 (pt) | 2020-06-30 |
AU2022224829A1 (en) | 2022-09-29 |
JP2020523322A (ja) | 2020-08-06 |
EP4241769A2 (en) | 2023-09-13 |
KR20230031370A (ko) | 2023-03-07 |
AU2018282905B2 (en) | 2022-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2019014772A (es) | Formulaciones en gel de bisfosfocinas y usos de estas. | |
EP3452597A4 (en) | METHODS AND COMPOSITIONS OF BIOLOGICALLY ACTIVE AGENTS | |
CA2956871C (en) | Compounds active towards bromodomains | |
PH12017501611A1 (en) | Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof | |
MX2019012978A (es) | Composiciones para el cuidado bucal y metodos para utilizar las composiciones. | |
MX2017011997A (es) | Carbamatos de piperacina y metodos de preparacion y uso. | |
EP3710036A4 (en) | STABLE ASCORBIC ACID COMPOSITIONS AND METHOD FOR THEIR USE | |
EP3474869A4 (en) | COMPOSITIONS DERIVED FROM HUMAN TISSUE AND USES THEREOF | |
MX2019010984A (es) | Composiciones de sintecina y metodos de uso. | |
EP3570826A4 (en) | N-ACETYLCYSTEIN FORMULATIONS AND THEIR USES | |
MX2018013184A (es) | Composiciones de saponinas y extractos vegetales. | |
EP3687491A4 (en) | HAIR CARE COMPOSITIONS AND METHODS | |
PH12020550217A1 (en) | Nutrient-spore formulations and uses thereof | |
MX2021016050A (es) | Formulaciones transdermicas. | |
MX2019011613A (es) | Formulaciones de acido 1-amino-1-ciclopropanocarboxilico. | |
EP3701942A4 (en) | SOLUBILIZATION OF CHLORHEXIDINE BASE, ANTISEPTIC AND DISINFECTANT COMPOSITIONS | |
WO2016130581A3 (en) | Combination cancer therapy | |
MY178960A (en) | Hiv treatment formulation of atazanavir and cobicistat | |
MX2020013389A (es) | Composiciones de terlipresina y usos de las mismas. | |
PH12018501758A1 (en) | Oritavancin formulations | |
EP3644971A4 (en) | CLOSTRIDIAL NEUROTOXIN FORMULATIONS AND USE | |
MX2020001632A (es) | Composiciones que comprenden cepas bacterianas. | |
MX2019010640A (es) | Formas cristalinas de acido obeticolico. | |
MX2021014806A (es) | Composiciones para el cuidado bucal y sus usos. | |
EP3664800A4 (en) | THERAPEUTIC FORMULATIONS AND USES THEREOF |